Oxidative stress and diabetic neuropathy: Current status of antioxidants

IIOAB Journal

Volumn 2, Issue 6, 2011, Pages 71-78

  Negi, Geeta ^a   Kumar, Ashutosh ^a   Joshi, Rayanta P ^a   Ruby, P K ^a   Sharma, Shyam S ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Antioxidants; Biomarkers; Diabetic neuropathy; Mitochondria; Oxidative stress

Indexed keywords

2 [[4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]METHYL] 3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 6 OL; ACETYLCYSTEINE; ACTOVEGIN; ADVANCED GLYCATION END PRODUCT; ALDOL; ALLOPURINOL; ANTIOXIDANT; APOCYNIN; ASCORBIC ACID; BK C 0701; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CURCUMIN; MELATONIN; METANX; MITOCHONDRIAL ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; NORPHENAZONE; PROBUCOL; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; RESVERATROL; TEMPOL; THIOCTIC ACID; TOCOPHEROL; TROLOX C; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; DIABETIC NEUROPATHY; DRUG TARGETING; GENE THERAPY; HUMAN; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW;

EID: 84865447807     PISSN: 09763104     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Vincent AM, Edwards JL, Sadidi M, Feldman EL. [2008] The antioxidant response as a drug target in diabetic neuropathy. Current drug targets 9:94-100.
2. Kohen R, Nyska A. [2002] Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30:620-650.
3. Lebovitz RM, Zhang H, Vogel H et al. [1996] Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A 93:9782-9787.
4. Matés JM. [2000] Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 153:83-104.
5. Xie C, Lovell MA, Xiong S et al. [2001] Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell line increases resistance to oxidative stress. Free Radic Biol Med 31:73-81.
6. Negi G, Kumar A, Sharma SS. [2011] Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-kappaB and Nrf2 cascades. J Pineal Res 50:124c131.
7. Reiter RJ, Tan DX, Maldonado MD. [2005] Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res 39:215-216.
8. Coppey LJ, Gellett JS, Davidson EP, Yorek MA. [2003] Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic Res 37:33-40.
9. Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA. [2000] Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49:1006-1015.
10. Nishikawa T, Sasahara T, Kiritoshi S et al. [2003] Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 26:1507-1512.
11. Kennedy JM, Zochodne DW. [2005] Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage? Diabetes 54:830-837.
12. Obrosova IG, Drel VR, Pacher P et al. [2005] Oxidative-nitrosative stress and poly (ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 54:3435-3441.
13. Guo C, Quobatari A, Shangguan Y, Hong S, Wiley JW. [2004] Diabetic autonomic neuropathy: evidence for apoptosis in situ in the rat. Neurogastroenterol Motil 16:335-345.
14. Burnand RC, Price SA, McElhaney M, Barker D, Tomlinson DR. [2004] Expression of axotomy-inducible and apoptosis-related genes in sensory nerves of rats with experimental diabetes. Brain Res Mol Brain Res 132:235-240.
15. Kamiya H, Zhang W, Sima AA. [2006] Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats. Diabetologia 49:2763-2774.
16. Zherebitskaya E, Akude E, Smith DR, Fernyhough P. [2009] Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes 58:1356-1364.
17. Brownlee M. [2005] The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625.
18. Toth C, Rong LL, Yang C et al. [2008] Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes 57:1002-1017.
19. Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JE. [2006] Diabetes and advanced glycoxidation end products. Diabetes care 29:1420-1432.
20. Cameron NE, Cotter MA. [2002] Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism. Diabetes Metab Res Rev 18:315-323.
21. Cotter MA, Jack AM, Cameron NE. [2002] Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes. Clin Sci (Lond) 103:311-321.
22. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. [2002] Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622.
23. Sima AA, Calvani M, Mehra M, Amato A. [2005] Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care 28:89-94.
24. Negi G, Kumar A, Kaundal RK, Gulati A, Sharma SS. [2010] Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy. Neuropharmacology 58:585-592.
25. Arora M, Kumar A, Kaundal RK, Sharma SS. [2008] Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimenatal diabeic neuropathy. European journal of pharmacology 596:77-83.
26. Negi G, Kumar A, Sharma SS. [2010] Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy. Biochem Biophys Res Commun 391:102-106.
27. Kumar A, Kaundal RK, Iyer S, Sharma SS. [2007] Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci 80:1236-1244.
28. Kumar A, Sharma SS. [2010] NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem Biophys Res Commun 394:360-365.
29. Saini AK, Kumar HSA, Sharma SS. [2007] Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy. European journal of pharmacology 568:164-172.
30. Sharma S, Chopra K, Kulkarni SK. [2007] Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother Res 21:278-283.
31. Sharma SS, Sayyed SG. [2006] Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy. Clin Exp Pharmacol Physiol 33:1022-1028.
32. Sayyed SG, Kumar A, Sharma SS. [2006] Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy. Life Sci 79:777-783.
33. Cotter MA, Cameron NE. [2003] Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci 73:1813-1824.
34. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK. [1994] Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37:449-459.
35. Chew GT, Watts GF. [2004] Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the recoupling hypothesisâ™. QJM 97:537-548.
36. Armstrong JS. [2007] Mitochondrial Medicine: Pharmacological targeting of mitochondria in disease. British Journal of Pharmacology 151:1154-1165.
37. Szeto HH [.006] Mitochondria-Targeted Peptide Antioxidants: Novel Neuroprotective Agents. The AAPS Journal 8:E521-E531.
38. Lin TK, Hughes G, Muratovska A et al. [2002] Specific modification of mitochondrial protein thiols in response to oxidative stress: a proteomics approach. J Biol Chem 277:17048-17056.
39. Zanetti M, Sato J, Katusic ZS, O'Brien T. [2001] Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta. Am J Physiol Heart Circ Physiol 280:H2516-2523.
40. Ishihara T, Tanaka K, Tasaka Y et al. [2009] Therapeutic effect of lecithinized superoxide dismutase against colitis. J Pharmacol Exp Ther 328:152-164.